MedTrace Logo

Pain in Inflammatory Joint Diseases

NCT06718569 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 350

Last updated 2026-04-13

No results posted yet for this study

Summary

Our primary objective is to better understand the etiology and consequences of chronic paint by using an explorative approach to identify phenotypes and endotypes of patients with inflammatory joint diseases, with a special focus on central sensitization and cognitive functioning as a key element in chronic pain. We will also examine the risk factors and clinical impact of these factors on pain, disease activity and treatment effects in a longitudinal study of patients with inflammatory joint disesases.

Conditions

  • Arthritis
  • Arthritis, Juvenile Idiopathic
  • Arthritis,Rheumatoid
  • Arthritis, Reactive
  • Arthritis, Psoriatic
  • Spondyloarthritis (SpA)

Interventions

DRUG

Biological or targeted synthetic DMARD

All biological or targeted synthetic DMARDs that are available for treatment of patients with inflammatory joint diseases

Sponsors & Collaborators

  • Diakonhjemmet Hospital

    lead OTHER

  • University of Oslo

    collaborator OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-11-11
Primary Completion
2027-11-30
Completion
2027-11-30

Countries

  • Norway

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06718569 on ClinicalTrials.gov